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The economic liberalization in India was expected to boost the economy, particularly
the industrial sector through faster technological development. The Schumpeterian
hypothesis, which studies the relationship between market structure variables such as
firm size and market concentration and their relationship with innovative activity, has
been exhaustively tested in the context of the developed countries and India. An attempt
is made in the paper to study this relationship with reference to India’s economic
liberalization. Hoping to overcome some of the problems of the earlier studies
conducted in India, the paper tries to develop a new analytical framework for studying
this relationship. Innovative activity is conceptualized here as a combination of in-house
R&D and the import of technology after India’s liberalization. Using probit and tobit
models, the study analyses the firm-specific, product-specific and industry-specific
factors which affect the investment decision to undertake innovation and the intensity of
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the innovative activity. The examination is carried out for two industries from the
manufacturing sector, viz. drugs and pharmaceuticals and electronics. The probit and
tobit estimates indicate that the factors affecting the decision to invest in innovative
activity and its intensity differ for the manufacturing industries under review,
highlighting the presence of technological opportunities across industries. The analysis
also shows that there is no evidence to support the assumption that large-sized firms
with market power are more innovative. There are also inter-industry differences in the
factors affecting innovative activity, which confirms the role of technological
opportunity after economic liberalization in India.1
1 Introduction
Since the 1940s economists have come to recognize the role of innovative activity in the
productivity growth of firms, particularly in competitive market economies. The
competitive environment in such economies acts as a major inducement for firms to
constantly upgrade their technology through research and development (R&D). Even in
less developed countries, innovative activity is increasingly becoming an important
factor of growth and survival of firms. The role of technology has assumed added
significance in the context of globalization wherein the survival of firms depends
mainly on international competitiveness.
However, technological change in the developing countries, as compared to developed
economies, has not received adequate attention. Technological activity in the developing
countries consists mainly of the import of technology—technology that is generated by the
industrialized nations and its adaptation to local conditions. Prior to liberalization, the
technology policy in India focussed mainly on the development of in-house R&D.
Therefore, the decision by firms to purchase technology was not easy. There were a
number of restrictions on industrial licensing, on the import of technology and technology-
embodying inputs and on foreign direct investment. While there were additional taxes on
technological imports, a number of incentives were provided to firms with recognized
R&D units. Since economic liberalization, there has been a shift in focus wherein the
import of technology, both embodied and dis-embodied, became an easy option. It was
hoped that the ongoing wave of globalization would enhance the flow of technology into
India and help to build much-needed technological capability. However, as Kumar and
Siddharthan argue:
While it is true that developing countries can benefit from the global pool
of technologies and knowledge by several channels of transfer and
diffusion and not reinvent themselves, literature has emphasized the need
for some capability of their own even to be able effectively to employ
technologies available abroad in the process of their development
(1997: 2).
1.2 Problem of the study
Having identified technological change as a major source of growth in the
developed country context, the process of technological change has been subjected to
intense study. There are studies that try to examine the nature of the process by which
economic resources are transformed into technological advancement. Related issues of
whether such a process exhibits increasing, decreasing or constant returns to scale and
the involvement of significant spillover effects are also addressed.
Determining the most conducive market environment for innovative activity also has
become the subject of interest ever since the pioneering work of Schumpeter (1942).
Schumpeter hypothesizes that firm size and market concentration induce innovative
activity. Since then, the hypothesis has been tested exhaustively in the
developed country context.1 Kamien and Schwartz (1982) summarize some important
                                                
1 A detailed discussion on the Schumpeterian hypothesis and a review of the empirical literature on the
test of Schumpeterian hypothesis in the developed country context are given in section two.2
issues of concern on market structure and technological change for developed country
economists, as follows:
What is the nature of the market for technical advances? Will the
competitive marketplace allocate resources so that the mix and timing of
the technological advances will be efficient? Is there a market structure
most conducive for technical advance? If so, is it sustainable? What is
the effect of technological advance on market structure? (1982: 12).
In the Indian context, studies relating to market structure and innovative activity
attained importance only in the 1970s. Since then, there have been numerous attempts to
empirically verify the Schumpeterian hypothesis in India. Most of these studies,
however, pertain to the import-substituting policy environment. Moreover, these studies
generally conceptualize innovative activity only in terms of in-house R&D. Given the
liberal policy environment, it is important that innovative activity is understood in terms
of both technology imports and in-house R&D. In addition to conceptual issues, there
are a number of methodological issues that need to be taken care of.2 In this context,
there arises a number of issues in terms of the relationship between firm size, market
structure and innovative activity. How do dynamic policy changes in the economy
during liberalization affect the market structure/innovative activity relationship? How
have the firm-specific, industry-specific and product-specific characteristics of firms
influenced innovative activity? What factors in a liberal environment affect the decision
to engage in innovative activity or determine its intensity? Another important issue for
analysis is the need to examine whether in the post-liberalization period there are
significant inter-industry differences in the relationship between market structure and
innovative activity.
Based on the above issues, the current study tries to look at the relationship between
firm size, market concentration and innovative activity for two industries of the
manufacturing sector: drugs and pharmaceuticals, and electronics. These two industries
are chosen because of their high technology-intensive nature.3
The specific objectives of the current study are to analyse:
i)  The firm-level relationship between market concentration, firm size and the
decision to do innovative activity, and
ii)  The factors influencing the intensity of innovative activity at the firm level.
The study is organized in four sections, including introduction. A review of the relevant
empirical literature on the relationship between market structure and innovative activity
is given in section two. The review is carried out against the backdrop of the
Schumpeterian hypothesis and highlights the relevance of the current study in present
day context, thereby setting the background for the analytical frame of the study. The
third section empirically tests the relationship between the variables for size and market
structure with the decision to innovate and the intensity of innovative activity for India’s
                                                
2  See section three for a discussion of the methodological issues.
3 The specific reasons for choosing these two industries are provided in section three.3
drug and pharmaceutical, and electronics industries. Section four summarizes the major
findings and presents the concluding observations.
2 Review of literature and analytical framework
Notwithstanding the general consensus on the positive role played by technology in
fostering economic efficiency and growth, economists differ in terms of the type of
economic structure that promotes innovation and technological progress. To begin with,
we have Schumpeter (1942) who believes that the introduction of new methods of
production and new commodities is not conceivable with perfect competition.
Conceptualizing innovation as the process encompassing new products, new processes,
new markets, new organization and new raw materials, Schumpeter underlines the key
role of monopoly power in bringing about innovation. However, neoclassical scholars
have held a diametrically opposite view: to them, a competitive market structure is
likely to be superior in terms of promoting innovation. Arrow (1962) has theoretically
articulated this argument, showing that under certain conditions, there is greater
incentive for R&D when industries are competitive than when monopolized. Arrow
concludes that the incentive to invent is smaller under monopolistic than under
competitive conditions, but even in the latter case it will be less than is socially
desirable. But Dasgupta and Stiglitz (1980) criticize Arrow on the grounds that he takes
market structure as given or exogenous and that he fails to take into account the
possibilities innovation opens for firms in an industry. Dasgupta and Stiglitz develop a
microeconomic model in which market structures are endogenous and the frontier of
technological possibilities specifically influences strategies involved in market
competition. They find that high research intensity and high level of concentration go
hand in hand. Industrial concentration and research intensity are simultaneously defined
in their model and therefore market structure, to a large extent, is determined by the
conditions for technological progress. Against this backdrop of diverging theoretical
arguments, there are essentially two strands of empirical literature: those exploring the
relation between market concentration and innovative behaviour; and studies on the
relation between firm size and innovative behaviour.
In this section, a modest attempt is made to critically review the available empirical
evidence on these issues. The underlying objective is to develop an analytical framework
for the present study.
2.1 Market concentration and innovation
According to Schumpeter, a monopolistic market structure induces greater innovation
than a competitive market structure. Technical advancement affects market structure in
two ways. The first is through influencing the optimal scale of production in an
industry. If the minimum efficient plant size (for example, the level of output at which
average cost is minimized) increases as a result of technical development, then there is a
tendency for the industry to become more concentrated. Second, market structure is
affected by the erection of entry barriers. The first firm to introduce a successful major
innovation may gain a significant advantage over its rivals. The advantage may be
derived from patents that cannot be easily circumvented, the development of expertise
that cannot be easily duplicated, the realization of extraordinary profits that are4
available for additional R&D, the development of a favourable reputation and a loyal
consumer base.
Kamien and Schwartz (1982) further articulate the manifold ways in which market
concentration and innovative behaviour interact. The first is between innovation and the
anticipation of monopoly power and its concomitant profits. The second source of
interaction is between innovation and the possession of monopoly power. A firm that
has a monopoly over its present products can simply extend it to new output, thanks to
its control of the channels of distribution, or through its reputation. The possession of
monopoly power and the associated profits may also enable the firm to respond more
quickly to rival innovations than it would otherwise. Another source of interaction
between the possession of monopoly power and innovation is alleged to be through the
necessity to finance innovation internally. A firm realising extraordinary profits is
presumably in a better position to undertake internal financing than a firm deriving its
profits from normal operations. Another advantage of the possession of monopoly
power is that firms can hire the most innovative people.
But Schumpeter cautions that sometimes monopoly power can act as a major disincentive
to innovation. It is possible that a firm enjoying monopoly profits has less incentive or
‘hunger’ to seek additional profits through innovation than a normally operating firm or a
new entrant. Thus, the question that remains to be answered is: Monopoly power is
advantageous to innovation, but how much is considered optimal? Moreover, as Usher
(1964) and Arrow (1962) point out, these firms are already reaping monopoly profits and
would prefer to capitalize as much as possible from the present product rather than attempt
to gain entry into a new market. For a new firm, if it is to enjoy monopoly power, there is
only one option.
Other than this, factors like technological and market opportunities are perceived to have
considerable influence on the level of technological activity. If firms find that the returns
from undertaking research in a specific area are greater than investments in another area,
then the innovative incentive would be different in each industry. Similarly, if the market
demand calls for changes in the nature of the product manufactured, then firms catering to
this market would be forced to respond to these expectations or face the risk of being
overtaken by rival improvements.
2.2 Empirical evidence on the relationship between market concentration
and innovative activity
Empirical studies on the Schumpeterian hypothesis in the developed countries have
mixed results to offer. Initial studies, like those of Scherer (1965) and Hamberg (1964)
report a positive but weak link between market concentration and R&D activity. Studies
by Williamson (1965), Bozeman and Link (1983), and Mukhopadhyay (1985) report a
negative relationship between concentration and R&D activity. Scherer (1967), for the
first time, observes a non-linear (inverted U) relationship between R&D intensity and
market concentration. Using data from the Census of Population, Scherer notes that
R&D employment as a proportion of total employment increases with concentration4 up
to a certain point, after which it decreases. Later studies by Levin et al. (1985) and Scott
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(1984), using the Federal Trade Commission data, also report the same non-linear
relationship.
Braga and Willmore (1991) find an inverted U-shaped relationship for a sample of
4,342 establishments in Brazil, for example. This implies that the extent of
concentration (measured in terms of the Herfindahl index) affects the probability of a
firm actively engaging in a specific product development programme up to a certain
level, after which market concentration has an adverse effect on the probability of
development.
Phillips (1966, 1971) was the first to propose that there could be causality between
market concentration and R&D, as ‘success breeds success’. Taking the case of the
aircraft market in America, he concludes that not only could concentration affect
innovation, but that the process could also work in reverse. Later studies by Farber
(1981), Connolly and Hirschey (1984), and Levin and Reiss (1991) examine the
relationship between market structure and R&D activity, treating both variables as
endogenous to avoid the simultaneity problem.
The study by Nelson and Winter (1982) uses simulation models to explain the positive
relationship between market concentration and innovative activity. They find that
market structure and innovative activity are both determined by such basic factors as
demand conditions, technological opportunities, government appropriability and the
nature of capital markets.
Geroski (1989, 1990, 1991) and Acs and Audretch (1991) study the relationship
between market ratio and innovation, with entry also taken into consideration. They
report that in the presence of entry, concentration has a modest negative relationship
with R&D intensity. Shrieves (1978) Comanor (1967) and Angelmar (1985) observe
that the market structure/innovative activity relationship is affected by other factors
such as technological opportunity, product differentiation, and entry barriers.
It was Scherer (1970) who notes that when inter-industry differences (due to
technological opportunities) are taken into account, the correlation between R&D and
other explanatory variables tends to become weaker and statistically insignificant.
Others, including Shrieves (1978), Levin and Reiss (1991), Cohen and Levinthal (1989)
and Geroski (1990), also use technology opportunity as a major variable to explain the
relationship between market structure and innovation.
Similar studies conducted in the developed  country context do not verify a positive
correlation between market concentration and innovation, as envisaged by Schumpeter.
While some studies find a weak positive link, many others give a negative relationship.
The major argument of these studies is that market concentration alone does not induce
innovative activity, but is supplemented by other factors. In addition to firm size and
market concentration, empirical studies also identify technological opportunity and
appropriability as important variables affecting innovative activity.
In India, the correlation between market concentration and innovative activity has been
empirically tested mainly in the 1980s. The Indian studies, similarly to those for the6
developed countries, also give mixed results.5 Desai (1988) analyses the relationship
between market structure and technological change on the basis of statistical correlation
as well as on the basis of a series of case studies for different industries. Based on the
1978-79 data from the Centre for Monitoring Indian Economy, he calculates the
Herfindahl concentration indices for 42 industries and an ‘E’ index6 of inequality. He
report s that market structures with a limited number of firms (two to six) are more
conducive to the adoption of new technology. Desai believes that the long tailed market
structure (large number of firms), which is common in India, is not especially conducive
to technological progress, nor are the government-established monopoly firms in high
technology industries.
Desai concludes that whilst technology imports on their own tend to create oligopolistic
market structures, R&D reinforces the competitive advantage of large firms. But the
leakage of technology within the country has led to the emergence of many small firms,
and they have appreciably increased their market shares. Due to inadequate firm-level
data, the analysis was limited to the industrial sector, and this could have constrained
the analysis, as the firm-level characteristics which might have affected innovative
activity were missing.
In a comprehensive coverage of industrial R&D in India, Kumar (1987) analyses 1,143
companies in 43 manufacturing industries, based on RBI data from 1976-77 to 1980-81.
Using a four-firm concentration ratio, Kumar explores the Schumpeterian hypothesis
with regard to the role of market structure. He aggregates the company-level data to
obtain the industrial-level data. The author controls for technological opportunity by
introducing proxy variables such as capital intensity, skill intensity, dummy variables
for engineering, chemical, consumer and consumer convenience goods, as well as
advertising intensity. The results show that the market structure variable (the four-firm
concentration ratio) attains a modest level of significance (10 per cent) with negative
sign. The neo-Schumpeterian expectation of a positive relationship between the seller
concentration and R&D intensity is, therefore, contradicted for the Indian industry. This
inverse relationship is explained by the presence of entry barriers. The government,
through its industrial licensing policy, protected firms from domestic as well as foreign
competition. Tariffs, non-tariff barriers and exchange controls shielded the industry
from foreign competition. Thus, existing firms faced virtual no actual or potential threat
from competition, and the principal motivation for pursuing innovation was to gain
monopoly power with its accompanying quasi-rents. Kumar, therefore, argues that in
the absence of any potential threat of competition, high concentration is not the
motivation for innovation. Capital intensity, a proxy variable for technological
opportunity, does show a significance, but negative relationship. This suggests that
capital-intensive industries do not offer technological opportunities. Other variables
denoting technological opportunity show no significance.7
                                                
5  For more detailed surveys on market structure/innovative activity relationship in the developed
country and Indian context, please refer to Kamien and Schwartz (1982), Kathuria (1989), Cohen
(1995), and Kumar and Siddharthan (1997).
6  E-measure of inequality refers to the Gini coefficient.
7  Kumar (1987), Siddharthan (1988) and Kumar and Saqib (1996) have taken care of appropriability
and technological opportunity in their studies.7
Vijayabhaskar (1991) deviates from earlier studies and tries to explore the association
between changes in concentration levels and sector performance in terms of output
growth and innovative activity in the 1980s. His logic is that as the liberalization
measures relaxed entry barriers, firms facing the threat of possible entry would respond
differently. The results show that low-intensity industries do benefit from high
concentration levels, as correlation coefficients are positive and significant (for both
periods). However, for high-intensity industries, the inverse is true, especially in the
post-liberalized period. The author concludes that high concentration or a monopolistic
market structure is hardly conducive to innovative activity in industries where they
really matter. Research intensity decreases with growing concentration levels, and there
is no positive correlation between concentration and innovativeness, as envisaged by the
proponents of liberalization. However, as the period of analysis was from 1980 to 1990
and economic liberalization in India took place only after the 1990s, it was not possible
for the study to obtain a clear picture of the relationship between market concentration
and R&D activity. The author also does not consider any form of technology import as a
measure of innovative activity. Data limitations confined the examination to an
industry-level analysis.
Prasad (1999) reports a negative relationship between in-house R&D and market
concentration, proxied by the market shares of firms in the chemicals sector and
industrial machinery sector, thus contradicting the Schumpeterian hypothesis. This firm-
level study, conducted in the late 1990s, does not consider the import of technology as a
significant measure of innovative activity, even though companies in the chemicals and
industrial machinery sectors have been technology import-intensive after liberalization
in India.
Kumar and Saqib (1996) find that both market concentration variables, proxied by four-
firm concentration ratio and profit margin, are negative but insignificant. This is true for
both the probit and tobit models used to analyse the probability and intensity of doing
in-house R&D.
2.3 Firm size and innovative activity
Although identified by Schumpeter, the firm size/innovative activity hypothesis was
fully developed by Galbraith (1952). According to the hypothesis, large firms are
proportionately more innovative than small firms. In other words, in a mature capitalist
economy, large firms generate a proportionately larger share of society’s technological
development.
Larger firms achieve certain advantages from greater innovative activity. One claim is
that capital market imperfections confer certain advantages to large firms in securing
finance for risky R&D projects, because size is associated with the availability and
stability of internally generated funds. Second, the scale of economies is associated with
industrial R&D. In addition, returns from R&D are higher in enterprises where the
innovator has a large volume of sales, over which to spread the fixed costs of
innovation. Finally, R&D is said to be productive in big companies because the
complementarities between research and development and other manufacturing
activities are better developed in these firms. Researchers are more productive when
they have numerous colleagues with whom to interact. A large group also permits the
division of labour. A large firm also has an advantage over its smaller counterparts in8
research and development due to its superior ability to exploit the output of its research
efforts. Based on these arguments, it is hypothesized that large firms generate more
innovation.
2.4 Empirical evidence on the relationship between firm size
and innovative activity
The hypothesis relating to firm size and innovative activity has been empirically tested
in the context of both the developed and developing countries, India included. The size
of firm has been alternately measured on the basis of employees, capital assets and sales
volume, and R&D intensity on the basis of related R&D expenditure, scientific
personnel engaged in R&D, patents received and sales associated with new products.
But there is no consensus on what exactly is the relationship between firm size and
innovative activity. In the developed country context, firm size has been measured as
the sales volume, the assets or the number of employees. Some studies by Comanor
(1967), Horowitz (1962) and Hamberg (1966) report a weak positive link between firm
size and innovative activity. All the above studies use a linear regression analysis or
correlation to arrive at the respective conclusion. However, with the exception of
Comanor (1967), these studies do not control for industry effects,8 and a later study by
Baldwin and Scott (1987) finds that this omission is likely to distort estimates on the
effects of firm size on innovative activity.
It was Scherer (1965) who first notes a negative relationship between firm size and
innovative activity. With a sample of 448 of the 500 largest firms in 1955, Scherer
regresses R&D employment with firm size to check for non-linearities. He finds that for
the smaller firms, firm size increases more than proportionately with innovative activity up
to certain threshold level. R&D employment intensity tends to decrease among the larger
firms.
Grabowski (1968) empirically tests the firm size and R&D intensity relationship in a
regression analysis, taking the size and square of size, for the drug and chemical firms.
He finds that the research intensity initially increases for the drug companies, but then
declines for most of the relevant range of firm sizes. In the case of chemical firms,
research intensity increases proportionately with firm size.9
Mueller (1967), Kelly (1970), Loeb and Lin (1977) all report that research intensity is
not positively correlated to firm size. While Mueller finds a negative relationship, Kelly
observes no relationship at all. The study by Loeb and Lin, analysing a 1961-72 time
series data relating sales to R&D expenditures for six major pharmaceutical
manufacturers, observes a non-linear relationship. Small firms are more research
intensive in Shrieves’ (1978) and Rosenberg’s (1976) analyses.
The 1980s witnessed the use of more comprehensive data to study firm size/R&D
relationship. Bound et al. (1984), using a sample of American firms, finds that R&D
intensity declines slightly with size among the smallest firms and then rises with size
among the very largest firms. Cohen et al. (1987) utilizing data from the Federal Trade
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9  Further data examination by Grabowski himself suggests that the observed relationship between firm
size and R&D intensity in the two industries is due to other factors affecting R&D intensity.9
Commission’s (FTC) line of business programme, and with due attention to industry
effects, report that firm size is not correlated to R&D intensity.
The studies examining the relationship between firm size and innovation used R&D
intensity, an innovative input, as a proxy for innovative activity. Fischer and Temin
(1973) argue that the empirical analysis should be done between firm size and R&D
output as proxy for innovative activity. They find that the elasticity of R&D with
respect to size in excess of one does not necessarily imply an elasticity of innovative
output with respect to size more than one.
The studies by Pavitt et al. (1987) and Acs and Audretsch (1990, 1991) show a
U-shaped relationship between R&D intensity and firm size. These indicate that very
small firms and very large firms have proportionately higher R&D intensities and that
the relationship pattern varies across industries.
Firm size and R&D relationship analyses in the developed country context are not in
tune with the positive relationship envisaged by Schumpeter. The general conclusion of
these studies is that research intensity (R&D/size) increases until a certain firm size, but
is then followed by a constant or declining period of intensity. Some studies also find a
negative relationship between firm size and innovative activity. Thus empirical
evidence does not offer a consensus to support the Schumpeterian hypothesis of large
firm size leading to greater innovation. The studies also conclude that firm size alone
cannot affect R&D intensity, and that other variables such as technological opportunity
and appropriability have an influence on R&D intensity.
The first attempt in India to empirically verify the Schumpeterian hypothesis is made by
Subrahmanian (1971a). He observes no evidence in the Indian chemical industry to
suggest a positive relationship between R&D intensity and firm size, nor between R&D
intensity and relative firm size (used to indicate market power). The major problem with
this analysis is that factors other than firm size are not considered. In a subsequent study
with the same dataset, Subrahmanian (1971b) includes other variables such as profits,
retained earnings, depreciation, gross investment and lagged R&D expenditure, and
reports that absolute R&D expenditure is positively related to firm size as well as to
lagged R&D and depreciation.
In another econometric study of R&D activity covering 100 engineering firms, Lall
(1983) observes that R&D intensity is positively influenced by the firms’ size, age and
technical absorptive capacity (proxied by the percentage of total wages and salaries paid
to employees earning more than Rs 3000 per month). Lall attributes this to the fact that
the largest firms tend to be more diversified, more technologically complex and could
afford more investment in R&D activities. However, Lall does not have a quadratic
term to check for non-linearities. Katrak (1985) observes that the elasticity of R&D
expenditure with respect to sales is less than unity for cross-section data at the industrial
level and his result contradicts Lall’s observations.10
Siddharthan (1988) argues that the relationship between the size of firm, and its conduct
and performance is seldom linear, as tested in earlier works. He uses published data
                                                
10 Kathuria (1989) argues that Katrak does not employ a variable, which would control for technological
opportunity and the study is based on industrial data, unlike Lall’s. However, Katrak (1989) again
reports a negative relationship between firm size and in-house R&D.10
from 166 manufacturing firms (both private and public firms) for the year 1983-84, and
reports a U-shaped non-linear relationship between R&D intensity and sales turnover
taken as a proxy for size. The turning point occurs at the sales level of Rs 600 million.
Non-linearity is mainly due to the fact that the nature and type of R&D activity between
large and small firms are different and thus not strictly comparable. He reports that the
increase in R&D expenditures for the smaller firms is slower than the increase in size,
while in the case of very large companies, it is faster than the growth in size. Testing
this relationship in industries such as electronics, machinery, textiles and chemicals,
Siddharthan observes a non-linear relationship between R&D intensity and firm size in
all industries, with the exception of chemicals where he notes a negative relationship.
But it should be noted that in this study, only firms which did some in-house R&D were
considered. Had non-R&D firms been included, it would have reduced the sample
selection bias and the result would have been different. Deolalikar and Evenson (1989)
analyse the determinants of inventive activity proxied by the average number of patents
(per firm) granted to Indian nationals. They report a negative relationship between
innovative activity and firm size.11
Katrak (1990) analyses the relationship between firm size and R&D activity for firms in
the electrical and electronics sector and in the industrial machinery sector, and observes
that an increase in firm size does not lead to a greater than proportionate increase in
R&D expenditure. Katrak (1994) is of the opinion that the influence of enterprise size
on technological effort depends on the industries concerned and the methodology used.
Katrak attempts to determine whether larger enterprises have a proportionately higher
output of in-house R&D based products. This is examined with a multiple regression
analysis using R&D based products as the dependent variable and the total value of the
enterprises’ total sales as a proxy for the size of the firm. The multiple regression
analysis indicates that the share of R&D based products decreases as the enterprise size
increases. The author assumes that this result could be due to the effect of government
policies. The industrial licensing policies (the data were for 1987) could have adversely
affected large-scale enterprises, which may have discouraged the R&D based
production.
Identifying the importance of technology imports as a major component of innovative
activity, Siddharthan and Krishna (1994) show that size is a positive and significant
variable in determining technology imports for firms belonging to six broad industry
groups, except in electrical and electronic goods and automobiles industries. With data
compiled from the annual reports of public limited companies, Basant (1996) studies the
technological strategies of large-scale enterprises in India by analysing 438 industrial
machinery firms and 651 chemical firms for the years 1974-84. The study, using
multinomial logit model, reports that large firm size improves the profitability/utility of
being technologically active (undertaking one’s own R&D, import of technology, or
both) relative to the reference state of no action. This is true in both the chemicals as
well as the machinery industries, but the choice of conducting R&D only is positively
affected by firm size in the chemical industry.12
                                                
11 A problem with this study could be that the analysis based on patents data need not give reliable
results and moreover India had a weak patent regime.
12 However, the author himself agrees that there is heterogeneity among the industry groups, especially
in chemicals. The firms are classified on the basis of their principal products and data limitations do11
Kumar and Saqib (1996) approach the problem using a probit and tobit model. They
observe from the probit model that firm size is positive and the quadratic term of firm
size is negative, with both being significant. This implies that the probability of doing
R&D increases up to a certain point and then declines. The tobit model shows that firm
size increases with R&D intensity in a linear fashion, with the quadratic term being
insignificant.
Subrahmanian  et al. (1996) and Prasad (1999) report evidence of a positive and
significant relationship between firm size and in-house R&D for post-liberalization data
on the industries in chemicals and electrical machinery. However, both studies consider
R&D intensity only and do not include the import of technology as an important
measure of innovative activity.
Empirical studies on firm size/innovative activity relationship in the Indian context also
show, as in the developed country context, widely diverging results. The results mostly
indicate a negative relationship between the two, but there are also studies, which show
a positive correlation. Siddharthan (1988) reports a U-shaped relationship between firm
size and in-house R&D activity, while Kumar and Saqib (1996) observe an inverted
U-shaped relationship between the two.
2.5 Towards an analytical framework
As is evident from the discussion so far, there is a vast body of literature in both the
developed countries and in India that empirically explore the Schumpeterian hypothesis.
However, there is no consensus with regard to the results of the analysis. The diverging
results could probably be explained by measurement problems associated with the
concept of innovation and market concentration on the one hand and empirical
procedures used in the estimation. Schumpeter conceptualizes innovation as a process
involving the introduction of new products, new processes, new markets, new raw
materials and new organization. However, the studies, in both the developed and
developing countries, consider only R&D expenditure, R&D employment or patents as
a proxy for innovation. Such a narrow measure of innovation can hardly represent the
innovation concept as used by Schumpeter. All measures of innovation used in
empirical studies have problems. According to Kamien and Schwartz (1982), patent
statistics, a common measure used to proxy innovation in the developed countries, has
the following problems:
i)  Patents are used for major as well as minor innovations; giving equal weights
for both is inappropriate;
ii)  Many patented products and processes are never commercialized; and
iii)  Many innovations are never patented.
The input measures of innovation (R&D employment and R&D expenditure) are also
widely used in studies in the developed country context. Scientists and research support
staff are at the core of the research organization and are directly involved in the conduct
                                                                                                                                              
not permit a detailed analysis of their levels of diversification. Given the heterogeneous nature of the
sample firms, the empirical exercise undertaken could not be a conclusive one.12
of research. In this case, time units spent on research must be identified, which is always
difficult. Kuznets (1962) calls for a study of specialized human capabilities to measure
the inventive capacity of personnel. Exact time units, mental effort and human ability
measures are beyond the scope of economics (Rajeswari 1992). Thus, the measure of
the research efforts of personnel fails to be a complete measure of its own. Research
expenditure is the most important quantifiable measure of research effort that is used in
empirical studies. It is a logical and direct measure, but can still be incomplete. Thus,
the diverse and incomplete measurement of innovation could be one of the reasons for
the observed variation of results in empirical studies.
The measurement of concentration is yet another problem faced by researchers. It is not
possible for a single concentration measure to capture all components of market
structure. The most commonly used index in the empirical studies in the developed and
Indian context is the K-firm concentration index, defined as the cumulative share of the
Kth firm. Its popularity is mainly due to easy availability of data and ease of
computation. The choice of K is, of course, arbitrary. Conventionally in developed
economies, K takes the value between 3 to 8. The problem with the measure is that it
does not disclose any information on firms ranked after K.
A more comprehensive measure of market concentration is the Hirschman-Herfindahl
index. It is defined as the sum of the squared shares of ‘n’ firms; its advantage is that it
takes into account the shares of all the firms in the market. At the same time, the
squaring up of the values means that smaller firms contribute less than proportionately
to the value of the index. This is a valid approach, as the entry of a number of small
firms with minuscule market shares would hardly affect the market power of the top
firms. But a prerequisite for this index is that information on the market shares of all
firms be available, a fact which restricts its use.
A problem common to these two measures is that they are static in nature and do not
capture movements in concentration levels, as top firms keep on changing their ranks
over the years. This is an obvious defect as the intensity of competition depends largely
on the ability of the top firms to maintain their position (Vijayabhaskar 1991). Still,
most of the empirical studies have taken a four-firm concentration ratio or the
Herfindahl index, as they are easy to compute and serve the purpose with little defects,
which usually can be ignored. However, these incomplete measures of concentration
could probably have resulted in the diverse results seen in the empirical studies
attempting to verify the market concentration/innovative activity relationship.
The problem deepens when it comes to the proxy used in empirical studies for
innovation in the Indian context. The studies have mostly taken R&D expenditure as a
proxy for innovation. The studies have assumed that innovation in both the developed
countries and in India is the same, a fact not true. It has been argued that R&D activity
in India was mainly informal and more adaptive in nature. Deolalikar and Evenson
conclude that:
One shortcoming of most studies on inventive activity in India is that
they limit themselves to formal inventive activity, often of the type that
takes place in established laboratories and results in patents. A large
majority of innovative activities among Indian firms takes place on the
shop floor. Often such activities play a more important role than formal
R&D in the technological development of the firm (1990: 244).13
Kumar and Siddharthan (1997) also report that the difficulties in capturing informal
innovative activity and the diverse measurements used to denote innovative activity are
the reasons why empirical studies on market structure and innovative activity in India
give contradicting results.
The studies in the Indian context also overlook the purchase of technology, another
important component of innovative effort. Given that the import of technology
increased significantly in India during the 1980s, the failure to incorporate this appears
to be a serious problem that needs to be corrected. Kumar and Siddharthan (1997: 55)
argue that ‘R&D expenditures only partially represented expenditures on technology, as
expenditures on technology purchases, which could be substantial, especially in the
developing countries are not covered, although the two could be related in some cases’.
Particularly after the liberalization of the 1990s, the purchase of technology became a
more important component of innovative activity. It can be hypothesized that large
firms, apart from doing more in-house R&D, also resort to added purchase of
technology than smaller firms because these are expected to have better knowledge of
world markets, as well as greater production and marketing experience than smaller
firms. Consequently, it is hypothesized that a large firm has more than a proportional
increase in technology purchases vis-à-vis smaller firms. It is also argued that foreign
companies prefer larger firms in technology licensing agreements (Evenson and Joseph
1997).
Inter-industry specificities or technological opportunities can play a major role in
determining the relationship between innovation and firm size, and innovation and
market concentration.13 Very few studies in India recognize inter-industry differences
in the Indian context. Understanding the importance of inter-industry differences in the
sample, Kumar (1987) introduces industry dummies to control for technological
opportunity. The problem is that in addition to technological opportunities, industry
dummies also represent other characteristics of the industry. Kumar and Saqib (1996) in
analysing the probability and intensity of firms that do R&D, also use industry dummies
to counter inter-industry differences. According to these authors, inter-industry
differences in the opportunities for product or process innovation play an important role.
The opportunities for adaptation vary across industries, depending on many factors,
including the maturity of technology, the gap between local and global standards, the
degree of monopolistic hold over technology, the nature of intellectual property
protection and the need for such adaptation arising from different local conditions.
Kumar and Saqib use a total of nine industry dummies to capture inter-industry
specificities for a sample of 291 manufacturing firms and find that technological
opportunity is very high in the chemicals and pharmaceuticals industry.
The best way to capture the inter-industry differences in the sample is to test the
hypothesis in different industries separately. Siddharthan (1988) attempts this in four
industries, apart from pooling the whole sample and testing the hypothesis, indicating
that inter-industry specificities are an important determinant of research effort and
should be included to obtain a reliable relationship between market structure and
innovative activity.
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country context that, apart from market concentration and firm size, technological opportunity and
appropriability are significant variables, which affect innovative activity.14
After a detailed critical survey of studies in India, Kathuria (1989: M120) concludes:
This strand of the technology literature of India, following in the mould
of its developed countries counterpart, suffers from the same limitations
as the latter but to an even greater degree, partly because of data
limitations. In addition, most of the earlier studies have used industry
rather than firm-level data, which tends to wash out the effect of
firm-level variables such as size, technical capacity, age and so on.
Goldar (1997) looks at the methodologies adopted in studies on innovative activity in
the Indian context. He believes that most of the studies are cross-section analyses with
problems of heteroscedasticity. He suggests that the ordinary least squares method used
in some of these studies is not a suitable method when variables such as export
orientation are related to innovative activity because of the simultaneity problem
between these variables. Goldar (1997: 95) observes that:
It should be noted that in many firms the R&D ratio in the sample is
negligible or zero. If such firms are included in the sample to estimate
the regression equation, estimation problems will be caused by the fact
that the dependent variable has a lower bound. If such firms are
excluded, the results get affected due to the sample selection bias. An
appropriate solution for tackling this problem is to use a tobit model, as
has been done by Kumar and Saqib (1996).
As seen above, the studies in the Indian context tested the Schumpeterian hypothesis in
the context of liberalization, using mostly a cross-section of firms or industries. The
economic liberalization in India was characterized by rapid policy changes over the
years. Thus, the cross-section studies undertaken in this context may not be sufficient to
capture the actual market structure/innovative activity relationship. A longer period of
analysis could have given better insights on the relationship between market structure
and innovative activity.
A number of issues arise, which warrant the need for a detailed study of the relationship
between market structure and innovative activity in the context of economic
liberalization. Studies based on firm-level data should include technology purchase as a
major source of innovative effort apart from in-house R&D, especially after
liberalization in India. The market structure/innovative activity relationship should be
examined so that, apart from size and market concentration, technological opportunity
and appropriability conditions are also considered. The study also should cover a longer
period of analysis to account for dynamic policy changes resulting from liberalization.
Moreover, there is scope for substantial methodological improvements by using the
probit and tobit estimates instead of OLS.
3 Empirical estimation
The previous section highlighted the conceptual and methodological problems
associated with the literature on market concentration, firm size and innovative activity.
The need to redefine the concept of innovation to capture the actual process taking place
in such developing countries as India has to be underlined. While the import of15
technology has generally been considered an important aspect of the innovation process
in most developing countries, India included, the existing literature seems to have
underplayed its role. There is need to attach due importance to the technological
opportunities of industries as well as the appropriability conditions. A longer period of
analysis, based on firm-level data may be more appropriate, especially when the period
of analysis is marked by flux in the policy environment. In addition to conceptual
refinement and changes, there is scope for improvement in the method of estimation as
well.
Against this background, the present section attempts to test the Schumpeterian hypothesis
in the context of the Indian economic liberalization for two industries: drugs and
pharmaceuticals, and electronics. The selection of these two industries is justified because
these are considered technology-intensive not only in terms of in-house R&D but also in
terms of the import of technology. While the drug and pharmaceutical industry has attained
prominence after liberalization by contributing most of the patents registered in India
(Prasad and Bhat 1993), numerous other studies14 identify the electronics industry as
technology-intensive. The study by Prasad (1999) reports that based on empirical analysis,
after liberalization these two industries have become the most technology-intensive in
terms of in-house R&D and the import of technology, respectively.
3.1 Issues, methods and hypotheses
As stated earlier, the innovative behaviour of Indian firms in the present study is
measured in terms of their total expenditure on the import of technology and in-house
R&D. A large number of firms do not invest in innovation, and the first issue that arises
is determining the probability of the firm engaging in innovative activities and the
factors that influence its innovation decision. Following Kumar and Saqib (1996), this
issue is approached using a probit model. Having analysed the innovation investment
decision, the second question concerns the intensity of innovative activity. This is
analysed using a tobit model. Drawing from existing literature, it is hypothesized that a
number of firm-specific, industry-specific and product-specific factors shape the
decision to invest in innovation and the intensity of innovative activity. Next is a brief
account of the theoretical base for incorporating these variables and their expected
relationship.
3.1.1 Firm size
Firm size is expected to have a positive influence on the decision and depth of in-house
R&D and technology purchases. Larger firms are better able to reap internal profits and
devote funds to risky endeavours than smaller firms and consequently are more involved
in-house R&D and the import of technology. Larger companies are preferred by
technology-exporting firms because of the higher royalty and lumpsum payments made by
these, an impossibility for many smaller firms. Large firms also benefit from the
economies of marketing, production, as well as greater certainty in information. Lall
(1983) is the first to note the positive influence of size on in-house R&D in India.
However, later studies (Subrahmanian1971a; Katrak 1985, 1989, 1990) in the
                                                
14 The technological intensity of electronics industry in India after liberalization is discussed in detail by
Joseph (1997) and Joseph and Subrahmanian (1994).16
pre-liberalization regime do not report a positive relation between firm size and R&D.15
However, it is assumed that under liberalization, large firms are able to take advantage of
the above mentioned benefits and thus a positive relationship between firm size and
innovative activity is assumed in the current study.
Some studies on India show a non-linear relationship between firm size and in-house
R&D. Siddharthan (1988) discovers that firm size first decreases with in-house R&D, and
then increases, showing a U-shaped relation. Kumar and Saqib (1996) observe an inverted
U-shaped relationship where the firm size increases to a certain extent, declining thereafter.
Therefore, a quadratic term for firm size is also used in the model to test for any non-
linearities between firm size and innovative activity.
3.1.2 Market concentration
The relationship between market concentration and innovative activity has also been
tested in both the developed and developing country context. The consensus of the
developed  country studies is that market concentration has only a weak positive
relationship with innovative activity. Furthermore, Kumar (1987) observes a negative
relationship in India between market concentration and R&D intensity. He argues that
as strong policy barriers restricted new entrants, the lack of competitive pressures in the
Indian industries retarded innovative activity. This is not the case in the liberalized
environment, in which firms are freer to engage in technological activity. Market
concentration in the current study is thus hypothesized to have a positive relationship
with the innovation decision and its intensity.
A dummy variable is used to differentiate firms with high market shares as compared to
firms with lower market shares for both industries. The top eight firms in each year for
each industry are assigned the value one and the value zero for others. This is a better
measure for capturing market concentration than conventional measures like the four-firm
concentration ratio or the Herfindahl index mentioned earlier.
Kumar and Saqib (1996) argue that a firm’s profit margin could also be an indication of
the competitive environment it faces. Profit margin is expected to have a positive impact
on innovative activity, as it helps to generate more internal funds. However, Geroski
(1990) points to the simultaneity bias involved in the profitability/R&D relationship, as
more R&D could also lead to more profits. In India, however, the study Kumar (1990)
shows no significant influence of R&D intensity on profit margins.
3.1.3 Appropriability
Other things being equal, a firm having a greater part of the production chain in-house
would have in-depth knowledge generated by innovative activity. This argument is put
forward by Arrow (1962) where he argues that appropriability, more than sales, is best
achieved by the internal application of knowledge. Therefore, a firm with a higher
value added to sales will have a better chance of investing in innovative activity. The value
added to sales differs from industry to industry, and this is accounted for in the current
study, as it is industry specific.
                                                
15 On the other hand, Subrahmanian et al. (1996) reports a positive relationship between firm size and
R&D activity using data from RBI.17
3.1.4 Experience
It is assumed that firms with long-term experience will have more intense innovative
activity. Older firms benefit because of accumulated learning and better ways of adapting
to new products. Consequently firms with experience are expected to have a positive
association with the decision to engage in innovation and its intensity. In the current study,
the age of the firms is taken as a proxy for experience, and older-aged firms are expected to
have a positive influence on innovative activity, both with regard to the R&D decision and
its degree of intensity.
3.1.5 Product market factor
Studies by Philips (1966) and Comanor (1967) in the developed  country context and
Kumar (1987) and Siddharthan and Krishna (1994) report that the possibility of conducting
in-house R&D and importing technology is more prominent in industries where products
are differentiable. Firms earmark funds for in-house R&D and technology imports to offset
risks introduced by competitors in the form of new products or improvements in already
available production. Advertisement intensity of the firms is used as a proxy here for
product differentiation and it is assumed that there is a positive association between
innovative activity and advertisement intensity.
3.1.6 Export orientation
It can be hypothesized that during liberalization export-oriented firms are able to invest
more forcefully in in-house R&D and the import of technology. Once firms are in a
position to gain access to international markets and to compete with foreign firms, they
spend more on in-house R&D and technology imports. Moreover, liberalization has
widened the market so that the cost of innovative activity is less than in the era of controls
in pre-liberalized regime. Braga and Willmore (1991) report that in Brazil there is a
positive significant relationship between exports as a ratio to sales and the probability of
doing in-house R&D. Export orientation is posited to favourably affect a firm’s innovation
decision, the intensity of in-house R&D, and the import of technology.
3.1.7 Foreign control dummy
A dummy variable is introduced to see whether the fact that firms have some permanent
foreign collaboration influences the probability and intensity of in-house R&D and the
import of technology. It can be hypothesized that firms with foreign collaboration are
more likely to spend more on innovative activity. Since the shares of foreign equity in
total equity are not available, import dividends paid abroad are used as a proxy for
measuring foreign collaboration. Siddharthan and Krishna (1994) observe that this
variable positively and significantly affects the import of technology in the drug and
pharmaceutical firms. Therefore, the dummy variable in this study takes the value one
for all firms that remit import dividends in foreign currency, and zero otherwise.
3.1.8 The data and the construction of variables
The data for the study have been collected for a six-year period (1992-97) from Prowess, a
corporate-level database published by the Centre for Monitoring Indian Economy. The
study is industry-specific and the firms are pooled for the analysis. The sample16 consists
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of 626 pooled observations for the electronics industry and 534 pooled observations for the
drug and pharmaceutical industry.
3.1.9 Variable construction
In the case of probit model, the dependent variable is a binary (0.1) variable depending on
whether or not the firms undertake any R&D or the import of technology. The probit
estimates give the conditional probability of an individual firm investing in innovative
activity for the given values of the explanatory variables. The dependent variable in this
model is PROBRDIMP. It takes the value one if the firms undertake either in-house R&D
or the import of technology or both, and zero otherwise. In-house R&D is proxied by the
total R&D expenditure to sales. The import of technology is captured by the royalty
payments, which constitute a regular flow of income abroad for the purchase of
technology. The data on the measures of in-house R&D and import of technology are
collected from the Prowess database.
The probit model used to test the above relationships for the two industries can be written
as:
PROBRDIMP* = b0 + b1 SALES + b2SALES2 + b3DCR4 + b4PROFIT+ b5ADS +
b6VALUE + b7EXPINT + b8AGE + b9DFOR
Here the dependent variable is a latent variable, which cannot be observed. Hence a
dummy variable, which is observed, is used and is defined by:
PROBRDIMP = 1  if  PROBRDIMP
*>0;
= 0  otherwise.
The intensity of doing innovative activity (RDIMPINT) is analysed using a tobit model.
This model is used to analyse the intensity of spending on innovative activity when a large
number of firms are not reporting any innovative activity. Here the dependent variable,
RDIMPINT for the tobit model for each industry, is equal to zero when the firms report
neither any R&D activity nor the import of technology and to the R&D intensity and
import of technology intensity for other firms.
The tobit model is defined as follows:17
RDIMPINT = b0 + b1 SALES + b2SALES2 + b3DCR4 + b4PROFIT + b5ADS +
b6VALUE + b7EXPINT + b8AGE + b9DFOR
if RDIMPINT >0; and
RDIMPINT = 0; otherwise.
Table 1 gives details of the variables used in the study, including the codes used and
definitions of the variables.
As the data on sales in the study are taken for a six-year period, it is necessary to deflate
these to standardize the variable. For both industries, sales are deflated with the wholesale
price index of the respective industries from 1992 to 1997, taking 1981-82 as the base year.
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Since all other variables are standardized by dividing them with sales, there is no need to
deflate these.
Table 2 gives the summary statistics of the variables used in the study for the two
industries: drugs and pharmaceuticals, and electronics. This highlights the inter-firm
differences, and nature, of the variables used in the sample. The correlation matrix of the
variables for the two industries shows that there is no presence of multicollinearity among
variables of the model. The heteroscedasticity problem has also been avoided as all
variables have been standardized by taking a ratio of these variables with sales.
Table 1
Variable construction and coding
Variable Code Definition
Probability of engaging in in-house
R&D plus the import of technology
PROBRDIMP It takes the value 1 for firms doing either R&D
or the import of technology or both, and 0
otherwise.
R&D intensity and the import of
technology intensity
RDIMPINT Ratio of R&D and the import of technology to
sales.
Sales SALES Value of sales in rupees (crores) deflated by the
wholesale price index of the corresponding
industry group for the period 1992 to 1997.
Sales
2 SALES2 Square of sales.
Market concentration DCR4 It takes a value one for firms, which have the
top eight market shares each year and zero
otherwise.
Advertisement intensity ADS Ratio of advertisement expenditure to sales.
Profit margin PROFIT Ratio of gross profit to sales.
Appropriability VALUE Ratio of gross value added to sales.
Export intensity EXPINT Ratio of exports to sales.
Experience AGE The age of the firm.
Foreign control dummy DFOR It takes a value 1 for firms which pays dividends
in foreign currency and zero otherwise.
Table 2
Summary statistics of the variables used in the model
Electronics for the drug and pharmaceutical sector and the electronics sector
Drugs and pharmaceuticals Electronics
Variable MEAN SD MIN MAX MEAN SD MIN MAX
RDIMPINT 0.008 0.014 0.0 0.107 0.012 0.046 0.0 0.62
SALES 59.5 78.2 0.21 446.3 72.2 150.8 0.05 977.1
PROFIT 0.005 0.29 -0.05 0.69 0.05 0.37 -0.005 0.45
VALUE 0.212 0.102 -0.28 0.79 0.27 0.19 -1.0 0.89
ADS 0.011 0.02 0.0 0.13 0.011 0.023 0.0 0.438
EXPINT 0.116 0.187 0.0 0.98 0.05 0.117 0.0 0.86
AGE 25.11 19.14 1.0 85.0 16.97 13.7 1.0 68.0
Note: Here SD means standard deviation.20
3.2 Empirical findings
3.2.1 Relationship between market structure variables and decision to do innovative
activity
The probit estimates for the two industries under review on the relationship between
market structure variables and the decision to do innovative activity show some
interesting results (Table 3).
The estimation of the probit models for both industries shows that there is a non-linear
relationship between firm size and innovative activity. The variable SALES is positively
significant and the variable SALES2 is negatively significant. This shows that only firm
size influences the decision to do innovative activity up to a certain point, declining
thereafter. Thus an inverted U-relationship is observed between the firm size and the
innovation decision for both industries. Siddharthan (1988) reports a U-shaped
relationship between firm size and in-house R&D. This implies that with liberalization,
small firms are more included to undertake R&D and technology imports than larger
firms. It is interesting to note that Kumar and Saqib (1996) obtain a similar inverted
U-shaped relationship between firm size and in-house R&D for the manufacturing
sector as a whole.
The market concentration variable does not show a positive relationship with the decision
to undertake innovative activity, as was expected for both industries. Kumar (1987) argues
that the lack of competitive pressures in the economy in the pre-liberalization era is the
reason for the negative relation between market concentration and innovation. The present
study shows that even after liberalization, market power of the firms does not influence the
decision to undertake innovative activity vis-à-vis other firms. But the variable is not
significant for both industries: on the part of the electronics industry, the profit margin
variable (another measure of concentration) shows a positive and significant relationship
with the R&D decision. This upholds the hypothesis that firms tend to engage in more
innovative activity by generating more internal funds in a liberalized environment with the
free entry of firms and no government controls. In the drug and pharmaceutical industry,
the variable is insignificant, highlighting the fact that profit margin and its influence on the
decision for innovative research vary from industry to industry.
The product market factor, proxied by the advertisement intensity (ADS) variable, shows
diverse results for the two industries. It shows a positive weak significant relationship with
the innovative-activity decision for drug and pharmaceutical firms. Siddharthan (1988)
reports that firms which spend more on advertisement engage more actively in in-house
R&D. Drug and pharmaceutical firms have mostly heterogeneous products and the R&D
incentive is stronger than in firms with homogenous products. In the electronics firms,
advertisement intensity shows a negative, albeit insignificant, relationship with innovative
activity.
The appropriability condition of the firms proxied by the value added-to-sales ratio
shows different results for the two industries. For the drug and pharmaceutical firms, a
positive although not significant relationship is seen between the value added-to-sales
ratio, which represents opportunities for the appropriation of innovation, and the
probability of doing innovative activity. Contrary to this, the electronics firms show a
negative and significant relationship with the value added-to-sales. This invalidates our
assumption that a greater production chain in-house has better scope of utilizing the
knowledge generated and the probability of doing innovative activity is high.21
The relationship with the export orientation of firms and the probability of innovative
activity shows some interesting results. Export intensity is found to have a positive, albeit
insignificant, effect on the innovation decision in the drug and pharmaceutical firms.
Export intensity for the electronics firms shows a positive and significant relationship with
the decision to undertake innovative activity. This means that, as hypothesized, the export
orientation of the electronics firms has a positive and significant effect on the probability
of participating in innovative activity.
The experience of the firms proxied by age and the effect of foreign control have a positive
and significant relationship with the innovation probability for both industries. There is
strong evidence, therefore, that firms with more production experience tend to provide
greater support to innovative activity. Similarly for the firms with some foreign control, the
probability of undertaking innovative activity is stronger.
Table 3
Probit estimates on the decision to do innovative activity for the drug and pharmaceutical,
and electronics industries
Variable Drugs and pharmaceuticals Electronics
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The probit analysis clearly shows some diverse results versus previous studies. There are
also considerable inter-industry differences in the factors determining the innovation
decision. The inverted U-shaped relation between firm size and the decision on innovative
activity highlights the role of small firms in each industry. Market power of the firms does
not affect the innovation decision, an observation also supported by other studies (Kumar
1987; Kumar and Saqib 1996). The variables proxying appropriability condition and
product market factor show diverse results for the two industries, clearly indicating that
technological opportunities vary among the different industries.
3.2.2Relationship between market structure variables and the intensity
 in the spending on innovative activity
Table 4 gives the maximum likelihood estimates of the tobit analysis on the market
structure variables that influence the intensity of innovative activity for the drug and
pharmaceutical, and electronics industries.
It can be noted that similar to the probability of engaging in innovative activity, the
SALES  and SALES2 variables are positively and negatively significant for both
industries. This means that firm size has an inverted U-shaped relationship with the
intensity of doing innovative activity. As the firm size increases, so does the intensity of
innovative activity to a certain threshold point, after which it declines. Thus the
hypothesis put forward by Schumpeter on a positive relationship between firm size and
innovative activity is not supported by this result.
Table 4
Tobit estimates on the intensity of innovative activity for drugs and pharmaceuticals and electronics
Variable Drugs and pharmaceuticals Electronics










































Log-likelihood ratio 569.34 313.23
No. of observations 534 626
Note: Figures in brackets show the ‘t’ ratios.
* Significant at 1% level: ** Significant at 5% level; *** Significant  at 10% level.23
The market concentration dummy variable and its correlation with the intensity of
innovation show some interesting results for the two industries. There is a negative but
insignificant relationship between market concentration and intensity of innovative activity
for the drug and pharmaceutical firms. This implies that the degree of competitive
pressures does not add to the intensity of innovation investments, as is seen in the
probability or decision to engage in innovative activity. This result substantiates the results
of studies conducted during the pre-liberalization period, including Kumar (1987) and
Kumar and Saqib (1996), who report a negative relationship. However, there is a positive
but insignificant relationship for the electronics firms. Thus the relationship between
market concentration and the intensity of innovative activity differs across firms in the two
industries.
The other concentration variable proxied by profit margin also shows a positive
relationship with the intensity of innovative activity. But it is significant only for the
electronics industry, implying that after liberalization, firms in both industries could have
generated internal funds to invest in in-house R&D and the import of technology during
high profit periods.
Advertisement intensity to sales, which proxies product market factors, shows a positive
relationship with the intensity of innovative activity for both industries. However it is
significant only in the drug and pharmaceutical firms. This means that expenditures on
R&D and the import of technology are higher in firms where products are differentiable
and aimed at gaining a competitive edge.
Appropriability condition of the firms for the two industries indicates diverse results in its
relation to innovative activity. On the part of electronics firms, the value added to sales is
observed to have a negative relationship with R&D and the import of technology. The
vertical integration of firms or the in-house production chain of firms does not influence
the intensity of innovative activity. But the variable is not significant. In the case of drug
and pharmaceutical firms, the value added to sales is noted to have a  positive and
significant effect on innovative activity.
The export orientation of the firms is observed to have a positive and significant influence
on the intensity of innovative activity for the electronics firms. This means that, similar to
the innovation decision, the export orientation of these firms significantly affects the depth
of innovative activity. This variable is also significant in the case of drug and
pharmaceutical firms.
Firms with some permanent foreign collaboration spend more on innovative activity. This
is more prominent among the electronics firms, but the variable is insignificant for drugs
and pharmaceuticals. While the experience of the firm is found to have a positive
relationship with the intensity of spending on in-house R&D on the part of the electronics
firms, it is insignificant for the drug and pharmaceutical firms. Thus, the age of the firm is
not a major factor affecting the intensity of innovative activity. It only has an effect in the
probability of undertaking innovative activity.
The tobit models thus show some interesting results. Deviating factors affect the intensity
of innovative activity on the part of the electronics and the drug and pharmaceutical
industries, thus highlighting the inter-industry differences. However, as in probit analysis,
there is a similar non-linear relationship between firm size and innovative activity for both
industries. Furthermore, value added, age and advertisement intensity show a positive24
significant relationship with innovation intensity for drugs and pharmaceuticals, but a
negative relationship for electronics. It is also noted that the foreign control variable and
profit margin affect the depth of innovative activity in electronics firms, but not in the drug
and pharmaceutical firms.
4 Summary and conclusions
The main focus of the present study is the analysis of the role of market structure
variables on a firm’s decision to participate in innovative activity and its depth. To test
for any inter-industry differences in the relationship, the study reviews two industries:
drugs and pharmaceuticals, and electronics. The study also attempts to determine
whether the same set of firm-specific, industry-specific and product-specific factors
affects the probability of undertaking innovative activity and its intensity for the two
industries.
In order to arrive at an analytical framework on the market structure/innovative activity
relationship, the available empirical literature is examined both in the context of both
developed countries and India. During this review, it is obvious that no consensus on the
results exists. An attempt is made to explain this in terms of the innovation concept used in
the studies as well as diverging empirical procedures. It is apparent that the studies mainly
use R&D expenditure, R&D employment and patent statistics as the major innovation
measures which, however, are incomplete with regard to Schumpeter’s definition of
innovation and pose certain limitations. In the Indian context, the studies do not include the
purchase of technology as a major component of the innovative effort. It is also apparent
that most of the studies on India utilize the OLS method. This introduces some inherent
problems and some methodological improvements (probit and tobit models) could have
given better insights.
The present study is based on firm-level data, prepared by the Centre for Monitoring
Indian Economy. The selection of this database is guided by its comprehensive nature
and easy accessibility as compared to official data sources for the post-liberalization
period. For analysing the relationship between market structure variables and the
probability and intensity of innovative activity, the period of analysis (1992-97) is
extended to account for the dynamic policy changes taking place after liberalization. In
the analysis, innovative activity is defined as the combination of in-house R&D and the
import of technology.
The study shows that there are significant differences for both industries in the factors that
affect the innovation decision and its  intensity. Firm size shows a non-linear (inverted U)
significant relationship with both the decision and intensity of innovative activity for both
industries. This implies that during liberalization the innovative activity of firms increases
with size upto a certain point, but declines thereafter. There is, however, an insignificant
negative relationship between market concentration and the innovation decision and its
intensity for both industries. This shows that contrary to our hypothesis, firms with market
power need not necessarily conduct more innovative activity. The value added variable
shows some interesting results for the two industries. While the value added has a positive
effect on the probability and intensity of innovative activity for the drug and
pharmaceutical industry, it shows a negative relationship on the part of the electronics
industry. This means that in the context of liberalization, a better in-house production chain25
in the drug and pharmaceutical industry is observed to significantly increase generated
knowledge and to have a positive influence on the innovation decision or its depth. But this
finding is invalid in the case of electronics firms. The export orientation of firms has, for
the electronics industry, a positive and significant impact on the probability of innovation
or its intensity, but for the drug and pharmaceutical firms, it has a positive and significant
relationship only with regard to the intensity of innovation.
A similar diverse result is seen in the case of the experience variable denoted by age and
the foreign collaboration dummy variable. Age of the firm significantly affects the decision
to undertake innovative activity for both industries but does not impact on its intensity.
Similarly, foreign collaboration significantly and positively affects the innovation decision
in firms in the drug and pharmaceutical industry, but is, on the one hand,  insignificant on
the part of the electronics firms. On the other hand, in electronic firms, foreign
collaboration impacts significantly on innovation intensity, but is insignificant for the drug
and pharmaceutical firms. The study indicates that for the drug and pharmaceutical
industry, only firm size and advertisement intensity significantly affect the innovation
decision or its depth. While age and foreign collaboration dummy are significant in the
decision to undertake innovative activity, the appropriability condition and export intensity
are the variables which significantly affect the intensity of innovative activity. For the
electronics industry, the firm size, value added, export intensity and foreign collaboration
dummy are the variables which influence both the decision to engage in innovation or its
intensity.
To sum up, the analysis shows that the factors that affect the relationship between market
structure and the probability of doing innovative activity are different from those which
impact on the intensity of innovative activity for both industries. This result confirms our
hypothesis that there are inter-industry differences in the factors affecting innovative
activity. There is no evidence to show that in the period of liberalization, firms with higher
market power and larger in size are able to do more innovative activity.
Selected references
Acs, Z. J., and D. B. Audretsch (1990). Innovation and Small Firms. Cambridge, MA:
MIT Press.
Acs, Z. J., and D. B. Audretsch (1991). Innovation and Technological Change: An
International Comparison. Oxford: Basil Blackwell.
Angelmar, R. (1985). ‘Market Structure and Research Intensity in High Technology
Opportunity Industries’. Journal of Industrial Economics, 34: 69-79.
Arrow, K. J. (1962). ‘The Economic Implications of Learning By Doing’. Review of
Economic Studies, 29: 155-73.
Baldwin, W., and J. Scott (1987). Market Structure and Technological Change.
London: Harwood Academic Publishers.
Basant, Rakesh (1996). ‘Technology Strategies of Large Enterprises in Indian Industry:
Some Explorations’. World Development, 25 (4).26
Bound, J., C. Cummins, Z. Grilliches, B. H. Hall, and A. Jaffe (1984). ‘Who Does R&D
and Who Patents?’, in Z. Grilliches (ed.), R&D Patents and Productivity. Chicago:
University of Chicago Press for NBER.
Bozeman, B., and A. N. Link (1983). Investments in Technology: Corporate Strategies
and Public Policy Alternatives. New York: Praeger.
Braga, Helson, and Larry Willmore (1991). ‘Technological Imports and Technological
Effort: In an Analysis of their Determinants Brazilian Firms’. The Journal of
Industrial Economics, 39: 421-32.
Cohen, W. M. (1995). ‘Empirical Studies of Innovative Activity’, in P. Stoneman (ed.),
Handbook of the Economics of Innovation and Technological Change. Oxford:
Blackwell, 182-264.
Cohen, W. M., and D. A. Levinthal (1989). ‘Innovation and Learning: The Two Faces
of R&D’. The Economic Journal, 99: 569-96.
Cohen, W. M., R. C. Levin, and David C. Mowery (1987). ‘Firm Size and R&D
Intensity: A Re-Examination’. The Journal of Industrial Economics, 35 (4): 543-65.
Comanor, W. S. (1967). ‘Market Structure, Product Differentiation and Industrial
Research’. Quarterly Journal of Economics, 81: 639-51.
Connolly, R. A., and M. Hirschey (1984). ‘R&D, Market Structure and Profits: A
Value-based Approach’. Review of Economics and Statistics, 66: 682-86.
Dasgupta, P., and J. Stiglitz (1980). ‘Industrial Structure and the Nature of innovative
Activity’. Economic Journal, 90: 266-93.
Deolalikar, Anil B., and Robert E. Evenson (1989). ‘Technology Production and
Technology Purchase in Indian Industry: An Econometric Analysis’. The Review of
Economics and Statistics, 71 (4): 687-92.
Deolalikar, Anil B., and Robert E. Evenson (1990). ‘Private Inventive Activity in Indian
Manufacturing: Its Extent and Determinants’, in R. E. Evenson and G. Ranis (eds),
Science and Technology: Lessons for Development Policy. Boulder: Westview Press.
Desai, Ashok V. (1988). ‘Technological Performance in Indian Industry: The Influence
of Market Structures and Policies’, in Ashok V. Desai (ed.), Technology Absorption
in Indian Industry. New Delhi: Wiley Eastern.
Evenson, R. E., and K. J. Joseph (1997). ‘Foreign Technology Licensing in Indian
Industry’. Working Paper No. 273. Thiruvananthapuram (India): Centre for
Development Studies.
Farber, S. (1981). ‘Buyer Market Structure and R&D Effort: A Simultaneous Equations
Model’. Review of Economics and Statistics, 62: 336-45.
Fischer, F. M., and P. Temin (1973). ‘Returns to Scale in Research and Development:
What does the Schumpetrian Hypothesis Imply?’. Journal of Political Economy, 81:
56-70.
Galbraith, J. K. (1952). American Capitalism: The Concept of Countervailing Power.
Boston: Houghton, Mifflin.
Geroski, P. A. (1989). ‘Entry, Innovation and Productive Growth’. The Review of
Economics and Statistics, 71 (4): 572-78.27
Geroski, P. A. (1990). ‘Innovation, Technological Opportunity and Market Structure’.
Oxford Economic Papers, 52: 586-602.
Geroski, P. A. (1991). ‘Market Dynamics and Entry’. Cambridge: Basil Blackwell.
Goldar, B. (1997). ‘Econometrics of Indian Industry’, in K.  L. Krishna (ed.),
Econometric Applications in India. New Delhi: Oxford University Press.
Grabowski, H. G. (1968). ‘The Determinants of Industrial Research and Development:
A Study of the Chemical, Drug and Petroleum Industries’. Journal of Political
Economy, 76: 292-306.
Greene, W. H. (1993). Econometric Analysis. New Jersey: Prentice-Hall.
Hamberg, D. (1964). ‘Size of Firm, Oligopoly and Research: The Evidence’. Canadian
Journal of Economics and Political Science, 30:62-75.
Hamberg, D. (1966). Essays on the Economics of Research and Development. New
York: Random House.
Horowitz, I. (1962). ‘Firm Size and Research Activity’. Southern Economic Journal,
28: 298-301.
Joseph, K. J. (1997). Industry under Liberalisation: The Case of Indian Electronics.
New Delhi: Sage Publications.
Joseph, K. J., and K. K. Subrahmanian (1994). ‘Technology, Trade and Product
Structure: A Conceptual Frame with a Case Study of Indian Electronics’.
Productivity, 34 (4).
Kamien, M. I., and N. L. Schwartz (1982). Market Structure and Innovation.
Cambridge: Cambridge University Press.
Kathuria, Sanjay (1989). ‘Market Structure and Innovation: A Study of Empirical
Studies of Schumpetrian Hypotheses for Developed Countries and India’. Economic
and Political Weekly, 24: M113-25.
Katrak, Homi (1985). ‘Imported Technology, Enterprise Size and R&D in a Newly
Industrialising Country: The Indian Experience’. Oxford Bulletin of Economics and
Statistics, 47: 213-30.
Katrak, Homi (1989). ‘Imported Technologies and R&D in a Newly Industrializing
Country: The Experience of Indian Enterprises’. Journal of Development Economics,
31.
Katrak, Homi (1990). ‘Import of Technology and the Technological Effort of Indian
Enterprises’. World Development, 18: 271-81.
Katrak, Homi (1994). ‘Imports of Technology, Enterprise Size and R&D Based
Production in a Newly Industrializing Country: The Evidence from Indian
Enterprises’. World Development, 22 (10): 271-81.
Kelly, T. M. (1970). ‘The Influences of Firm Size and Market Structure on the Research
Efforts of Large Multiple Product Firms’. Oklahoma State University. Mimeo.
Kumar, Nagesh (1987). ‘Technology Imports and Local Research and Development in
Indian Manufacturing’. The Developing Economies, 25: 220-33.28
Kumar, Nagesh (1990). Multinational Corporations in India. London and New York:
Routledge.
Kumar, Nagesh, and Mohammed Saqib (1996). ‘Firm Size, Opportunities for
Adaptation and In-House R&D Activity in Developing Countries: The Case of
Indian Manufacturing’. Research Policy, 25 (5): 712-22.
Kumar, Nagesh, and N. S. Siddharthan (1997). Technology, Market Structure and
Internationalisation: Issues and Policies for Developing Countries. UNU/INTECH
Studies in New Technology and Development. London: Routledge.
Kuznets, Simon (1962). ‘Inventive Activity: Problems of Definition and Measurement’,
in Rate And Direction of Innovative Activity. Cambridge, MA: National Bureau of
Economic Research.
Lall, S. (1983). ‘Determinants of R&D in a LDC: The Indian Engineering Industry’.
Economics Letters, 13: 379-83.
Levin, R. C., W. M. Cohen, and D. C. Mowery (1985). ‘R&D Appropriability,
Opportunity and Market Structure: New Evidence on Some Schumpetrian
Hypothesis’. American Economic Review, Papers and Proceedings, 75: 20-4.
Levin, Richard C., and Peter C. Reiss (1991). ‘Test of a Schumpetrian Model of R&D
and Market Structure’, in Z. Griliches, R&D, Patents and Productivity. Chicago and
London: University of Chicago Press, 175-204.
Loeb, Peter, and V. Lin (1977). ‘Research and Development in the Pharmaceutical
Industry: A Specification Error Approach’. Journal of Industrial Economics, 26:
45-51.
Maddala, G. S. (1983). Limited Dependent and Qualitative Variables in Econometrics.
Econometric Society Monographs. Cambridge: Cambridge University Press.
Mueller, D. C. (1967). ‘The Firm’s Decision Process: An Econometric Investigation’.
Quarterly Journal of Economics, 81: 58-67.
Mukhopadhyay, A. K. (1985). ‘Technological Progress and Change in Market
Concentration in the US, 1963-77’. Southern Economic Journal, July: 141-48.
Nelson, R. R., and Sidney G. Winter (1982). An Evolutionary Theory of Economic
Change. Cambridge, MA and London: Harward University Press.
Pavitt, K. et al. (1987). ‘The Size Distribution of Innovating Firms in the UK: 1945-
1983’. Journal of Industrial Economics, 35: 297-316.
Phillips, A. (1966). ‘Patents, Potential Competition and Technical Progress’. American
Economic Review, 56: 301-10.
Phillips, A. (1971). Technology and Market Structure: A Study of the Aircraft Industry.
Lexington, MA: Heath, Lexington Books.
Prasad, Ashok Chandra, and S. Bhat (1993). Strengthening India’s Patent System:
Implications for Pharmaceutical Sector’. Economic and Political Weekly, 28 (19):
1037-58.
Prasad, S. (1999). ‘Some Dimensions of Research and Development in India: An
Analysis with Special Reference to Post Liberalisation Scenario’. Trivandrum
(India): Centre for Development Studies. Unpublished M Phil Thesis.29
Rajeswari, S. (1992). ‘The Organisation of Agricultural Research in India: An
Economic Analysis of Technology Generation from 1860-1990. Kerala (India):
University of Kerala. PhD Thesis.
Rosenberg, J. B. (1976). ‘Research and Market Share: A Reappraisal of Schumpetrian
Hypothesis’. Journal of Industrial Economics, 25: 110-12.
Scherer, F. M. (1965). ‘Firm Size, Market Structure, Opportunity, and the Output of
Patented Inventions’. American Economic Review, 55: 1097-125.
Scherer, F. M. (1967). ‘Market Structure and the Employment of Scientists and
Engineers’. American Economic Review, 57: 524-31.
Scherer, F. M. (1970). Industrial Market Structure and Economic Performance.
Chicago: RandMcnally.
Schumpeter, J. A. (1942). Capitalism, Socialism and Democracy. New York: Harper.
Scott, J. T. (1984). ‘Firm Versus Industry Variability in R&D Intensity’, in Z. Grilliches
(ed.), R&D Patents and Productivity. Chicago: University of Chicago Press for the
NBER.
Shrieves, R. E. (1978). ‘Market Structure and Innovation: A New Perspective’. Journal
of Industrial Economics, 26: 329-47.
Siddharthan, N. S. (1988). ‘In-house R&D, Imported Technology and Firm Size,
Lessons from Indian Experience’. Developing Economies, 26: 212-21.
Siddharthan, N. S., and K. L. Krishna (1994). ‘Determinants of Technology Imports:
Evidence for Indian Firms’. Working Paper E/161/94. Delhi: Institute of Economic
Growth.
Subrahmanian, K. K. (1971a). ‘Market Structure and R and D Activity: A Case Study of
Chemical Industry’. Economic and Political Weekly, 6: August.
Subrahmanian, K. K. (1971b). ‘Determinants of Corporative R& D’. Economic and
Political Weekly, November: M169-M171.
Subrahmanian, K. K. (1991). ‘Technological Capability under Economic Liberalism:
Experience of Indian Industry in the Eighties’. Economic and Political Weekly, 26:
M87-9.
Subrahmanian, K. K. et al. (1996). ‘Foreign Collaboration under Liberalisation Policy:
Patterns of FDI and Technology Transfer in Indian Industry since 1991’.
Development Research Group Study, No.14. Mumbai (India): Department of
Economic Analysis and Policy, Reserve Bank of India.
Usher, D. (1964). ‘The Welfare Effects of Invention’. Economica, 31: 279- 87.
Vijayabhaskar, M. (1991). ‘Concentration in Indian Manufacturing Industry, 1970 to
1990’. Trivandrum: Centre for Development Studies. Unpublished M Phil Thesis.
Williamson, O. E (1965). ‘Innovation and Market Structure’. Journal of Political
Economy, 3: 67-73.